OBJECTIVE: To evaluate the frequency and correlates of oral route exposure of infants born to HIV-1-infected women. METHODS: A multicenter study was performed within the prospective French Perinatal Cohort Study of mother-to-child HIV transmission. Oropharyngeal and gastric aspirates from 122 neonates were studied by reverse transcriptase (RT) polymerase chain reaction (PCR) for the presence of HIV-1, as well as for standard microbiology (Gram staining and culture). RESULTS: Aspirates from 101 neonates were analyzed by RT-PCR; 28% of these were positive for HIV RNA. Another 21 aspirates could not be tested because of PCR inhibition. The median concentration of HIV RNA in the positive aspirates was 126 copies/ml (range: 8-1270). Detection of HIV-1 in the aspirate was significantly related to high maternal plasma-viral load, presence of blood in the aspirate, positive Gram stain or culture, episiotomy or perineal lesions, and sexually transmitted infections during the pregnancy. Most of the mothers received zidovudine prophylaxis during pregnancy and delivery. Among the six infants who were infected with HIV, three had positive aspirates. Of the three assumed to have acquired the infection intrapartum, only one had an HIV RNA-positive aspirate. CONCLUSION: Exposure of the fetus to HIV via the oral route occurs frequently, even in the presence of zidovudine prophylaxis, and is likely to be one of the mechanisms of intrapartum transmission, but not the only one.
OBJECTIVE: To evaluate the frequency and correlates of oral route exposure of infants born to HIV-1-infectedwomen. METHODS: A multicenter study was performed within the prospective French Perinatal Cohort Study of mother-to-child HIV transmission. Oropharyngeal and gastric aspirates from 122 neonates were studied by reverse transcriptase (RT) polymerase chain reaction (PCR) for the presence of HIV-1, as well as for standard microbiology (Gram staining and culture). RESULTS: Aspirates from 101 neonates were analyzed by RT-PCR; 28% of these were positive for HIV RNA. Another 21 aspirates could not be tested because of PCR inhibition. The median concentration of HIV RNA in the positive aspirates was 126 copies/ml (range: 8-1270). Detection of HIV-1 in the aspirate was significantly related to high maternal plasma-viral load, presence of blood in the aspirate, positive Gram stain or culture, episiotomy or perineal lesions, and sexually transmitted infections during the pregnancy. Most of the mothers received zidovudine prophylaxis during pregnancy and delivery. Among the six infants who were infected with HIV, three had positive aspirates. Of the three assumed to have acquired the infection intrapartum, only one had an HIV RNA-positive aspirate. CONCLUSION: Exposure of the fetus to HIV via the oral route occurs frequently, even in the presence of zidovudine prophylaxis, and is likely to be one of the mechanisms of intrapartum transmission, but not the only one.
Authors: Agnès-Laurence Chenine; Flavia Ferrantelli; Regina Hofmann-Lehmann; Mark G Vangel; Harold M McClure; Ruth M Ruprecht Journal: J Virol Date: 2005-01 Impact factor: 5.103
Authors: Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky Journal: Virology Date: 2010-11-05 Impact factor: 3.616
Authors: Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky Journal: J Virol Date: 2011-12-28 Impact factor: 5.103
Authors: Kristina Abel; Tracy Rourke; Ding Lu; Kristen Bost; Michael B McChesney; Christopher J Miller Journal: J Infect Dis Date: 2004-09-24 Impact factor: 5.226
Authors: L Mandelbrot; P Msellati; N Meda; V Leroy; R Likikouët; P Van de Perre; L Dequae-Merchadoux; F Sylla-Koko; A Ouangre; T Ouassa; R Ramon; L Gautier-Charpentier; M Cartoux; M Dosso; F Dabis; C Welffens-Ekra Journal: Sex Transm Infect Date: 2002-08 Impact factor: 3.519
Authors: Joseph Nyandwi; Sylvestre Bazikamwe; Désiré Nisubire; Pontien Ndabashinze; Mohamed Elsayed Shaker; Eman Said Journal: East Afr Health Res J Date: 2018-11-23